Spotify CEO Defends AI Music Integration Calls Remix Tool a Better Alternative to Unlicensed Slop Japans Megabanks Post Record Profits but Analysts Warn of Slowing Growth Amid Rising Credit Costs and Geopolitical Risks Sensex Nifty Wobble as Asian Paints and SBI Lead Gainers ONGC and Axis Bank Lag Accenture and HUMAIN Forge Partnership to Accelerate AI Adoption in Saudi Arabia US Payrolls Surge Past Expectations in April Though Underlying Concerns Persist USChina Trade Divergence Persists After TrumpXi Summit VALN Q1 2026 Earnings EPS Misses Expectations Amid Ongoing Operational Challenges FRAF Q1 2026 Earnings EPS Beats Estimates Stock Declines ECC Q1 2026 Earnings Earnings Miss Estimates Amid Stable Portfolio Performance FiEE Inc Q1 2023 Earnings EPS Misses Estimates by 41 Stock Slightly Down Moderna Inc MRNA Q1 2026 Earnings Narrowerthanexpected loss as cost controls offset revenue headwinds Digital Currency X Technology Inc DCX Edges Lower Amid Cautious Market Sentiment Fifth Era Acquisition Corp I Rights FERAR Faces Selling Pressure Tests Key Support at 028 Kiniksa Pharmaceuticals KNSA Holds Near Flat as Stock Consolidates Near Key Levels TPG RE Finance Trust TRTX Holds Steady Near Support as Commercial Real Estate Sentiment Shifts Bassett Furniture BSET Holds Steady Near Resistance as Volume Signals Caution Wingstop Shares Slide 12 After Quarterly Profit Misses Analyst Estimates TEO Q1 2026 Earnings Massive EPS Beat as Telecom Argentina Reports Stellar Results Photronics Inc PLAB Slips Slightly Amid Mixed Market Sentiment GYRE Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Surprise Amid Revenue Absence QVCGP Q3 2025 Earnings Significant Loss Per Common Share Reported Preferred Stock Unchanged WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22 PYPD Q1 2026 Earnings EPS Beat on Operational Discipline But Revenue Remains Absent LATAM Airlines Q1 2026 Earnings Narrow Profit Beat Fails to Lift Shares as Operational Headwinds Persist SCL Q1 2026 Earnings Slight EPS Beat Drives Positive Market Response Compass Therapeutics Q1 2026 Earnings Narrowerthanexpected Loss Fuels Investor Optimism